What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in
Centers for Disease Control and Prevention, Congressional Budget Office, Drugs (Pharmaceuticals), Elderly, Eli Lilly and Company, GLP-1 RAs (Drug), Health Insurance and Managed Care, Humana Inc, KFF (Nonprofit), Medicare, Novo Nordisk A/S, Obesity, Prices (Fares, Fees and Rates), Trump, Donald J, United States Politics and Government, Weight
Leave a Reply